study, including urinary tract infections and medications. It is probable that the four specimens with nitrite concentrations in excess <strong>of</strong> 100 tJg/mL were contaminated by enterobacteriaceae and had sufficient nitrate present to achieve these levels. In contrast to these specimens, which were allowed to incubate at room tem- perature, 15 other drug-negative specimens were selected at random from 60 in an initial test batch and tested for nitrite con- centration. The data are not contained in the table because all 15 were below the limit <strong>of</strong> detection <strong>of</strong> the method, 0.6 IJg/mL. These data illustrate that specimens more typical <strong>of</strong> the age <strong>of</strong> workplace drug-testing specimens, 12-24 h, tend to be negative or have low concentrations <strong>of</strong> nitrite, whereas those that are allowed to incu- bate can reach concentrations relatively high for nonadulterated specimens. 94 Table IV. <strong>Nitrite</strong> Concentrations in <strong>Urine</strong> <strong>Specimens</strong> Received for Employment <strong>Drug</strong> <strong>Testing</strong> which were Initial Test Negative and Held at Room Temperature for 2-3 Weeks <strong>Nitrite</strong> (pg/mL) Specimen No. 2weeks 3weeks 1 19.7 33.8 2 121.2 121.2 3 37.1 36.8 4 43.0 37.4 5 6.9 7.2 6 34.8 33.8 7 122.2 118.6 8 43.0 39.7 9 6.9 7.2 10 34,2 36.1 11 128.1 129.1 12 42.7 37.8 13 6.2 7.2 14 43.7 36.4 15 63.7 116.9 Average 50.2 53.3 Range 6.2-128.1 7.2-129.I Table V. Sources <strong>of</strong> <strong>Nitrite</strong> in <strong>Urine</strong> and Approximate Concentrations Achievable From Them* Source Approximate nitrite concentration (pg/mL) Internal sources Urinary tract infection 150 Palhological conditions 100 Normal biochemistry Trace External source.g Medications 25 All other natural sources Food, water, air, occupational exposure, induction by medications
Journal <strong>of</strong> Analytical Toxicology, Vot. 22, March/April 1998 in the range <strong>of</strong> that obtained by adulteration were to arise in the urine from filtration <strong>of</strong> the blood in the kidneys, the donor would be in a toxic, life-threatening circumstance at the time <strong>of</strong> voiding. Symptoms <strong>of</strong> nitrite poisoning include headache, nausea, vom- iting, diarrhea, convulsions, and coma. This would be obvious to the collector and anyone else in the donor's presence. The posi- tive initial test result and the typical pattern in the confirmatory test are evidences <strong>of</strong> motive on the part <strong>of</strong> the donor to adulterate. A concentration <strong>of</strong> 1000 IJg/mL or greater <strong>of</strong> nitrite ion, deter- mined with a well-structured and documented analysis, is scien- tifically valid and forensically defensible pro<strong>of</strong> <strong>of</strong> adulteration <strong>of</strong> the specimen with a nitrite-containing substance. A cut<strong>of</strong>f con- centration between 500 and 1000 pg/mL may also be supportable. Part II <strong>of</strong> this series will present a quantitative method for analysis <strong>of</strong> nitrite in urine, and will suggest a test algorithm for detecting and reporting nitrite adulteration. Acknowledgment The authors acknowledge the excellent, pr<strong>of</strong>essional assis- tance <strong>of</strong> the Utah State Health Laboratory in performing instrumental analysis for nitrite as used in public health envi- ronmental monitoring programs. References 1. M.A. EISohly, S. Feng, W.J. Kopycki, T.P. Murphy, A.B. Jones, A. Davis, and D. Carr. A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis <strong>of</strong> 11-nor-Ag-THC - 9-COOH. J. Anal. Toxicol. 21 9 240--242 (1997). 2. D.R. Smith. Reporting <strong>of</strong> drug test results: abnormal test results and analysis for presence <strong>of</strong> adulterants. <strong>Drug</strong> Enforcement and Program Compliance Office, Department <strong>of</strong> Transportation, December 7, 1993. 3. Method 353.2, Determination <strong>of</strong> Nitrate-<strong>Nitrite</strong> Nitrogen by Auto- mated Colorimetry. Revision 2.0. J.W. O'Dell, Ed. Inorganic Chem- istry Branch, Chemistry Research Division, Environmental Monitoring Systems Laboratory, U.S. Environmental Protection Agency, Cincin- nati, OH, August 1993. 4. L. Green, K. Ruiz de Luzuriaga, D. Wagner, and W. Rand. Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. 78:7764 (1981). 5. L. Green, S. Tannenbaum, and P. Goldman. Nitrate synthesis in the germ-free and conventional rat. Science 212" 56 (1981 )~ 6. H. Moshage. Nitric oxide determinations: much ado about NO- thing. Clin. Chem. 43(4): 553-556 (1997). 7. A. Wennmalm, G. Benthin, and A. Petersson. Dependence <strong>of</strong> the metabolism <strong>of</strong> nitric oxide (NO) in healthy human whole blood on the oxygenation <strong>of</strong> its red cell haemoglobin. Br. J. PharmacoL 106: 507-508 (1992). 8. H. Moshage, B. Kok, J. Huizenga, and P. Jansen. <strong>Nitrite</strong> and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41(6): 892-896 (1995). 9. S. Hovenga, M. Koenders, T. van der Weft, H. Moshage, and J. Zijl- stra. Methemoglobinaemia after inhalation <strong>of</strong> nitric oxide for treat- ment <strong>of</strong> hydrochlorothiazide-induced pulmonary oedema. Lancet 348:1035-1036 (1996). 10. S. Moncada, R. Palmer, and E. Higgs. Nitric oxide: physiology, patho- physiology, and pharmacology. PharmacoL Rev. 43:109-142 (1991). 11. K. Sasajima, Y. Yoshida, S. Yamakado, S. Sato, M. Miyashita, M. Onda, and E. Kawano. Changes in urinary nitrate and nitrite during treatment <strong>of</strong> ulcerative colitis. Digestion 57(3): 170-173 (1996). 12. D. Wagner and S. Tannenbaum. Enhancement <strong>of</strong> nitrate biosynthesis by Escherichia coil lipopolysaccharide. In Nitrosamines and Human Cancer. P.N. Magee, Ed. Banbury Rep. 12:437~,43 (1982). 13. O. Weltmann. Method for the simple detection <strong>of</strong> urinary tract infec- tions. Wien. Med. Wschr 72:618 (1922). 14. R Griess. Bermerkungen zu der Abhandlung der HH. Wesley and Benedikt Ueber einige Azoverbindungen, Ber Deutsch Chem Gen 12:426 (1879). 15. Package insert, ChemstripTU 6,7,8,9,10 with SG. Boehringer Mannheim Corporation, Indiannapolis, IN, 1994. 16. D. Granger, R. Taintor, K. Boockvar, and J. Hibbs, Jr. Measurement <strong>of</strong> nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. In Methods in Enzymology, VoL 268 Nitric Oxide, Part A, Sources and Detection <strong>of</strong> NO; NO synthase. L. Packer, Ed. Academic Press, New York, NY, 1996, p 143. 17. S. Smith, M. Wheeler, and R. Weiss. Nitric oxide synthase: an endoge- nous source <strong>of</strong> elevated nitrite in infected urine. Kidney Int. 45: 586-591 (1991). 18. K. Lee, J.L. Greger, J. Consaul, K. Graham, B. Chinn. Nitrate, nitrite bal- ance, and de novo sythesis <strong>of</strong> nitrate in humans consuming cured meats. Am. J. Clin. Nutr. 22(4): 188-194 (1986). 19. S. Tannenbaum. A Policy Perspective on Safety: <strong>Nitrite</strong> and Nitrate. H<strong>of</strong>fman-LaRoche Inc., Nutley, NJ 1984, p 12. 20. 40 Code <strong>of</strong> Federal Regulations, Part 141.23, revised July 1, 1994, p 675. 21. R. Saul and M. Archer. Nitrate formation in rats exposed to nitrogen dioxide. ToxicoL AppL Pharmacol. 67(2): 2379-2382 (1983). 22. C Hogstedt and K. Andersson. A cohort study <strong>of</strong> mortality among dyna- mite workers. J. Occup. Med. 21: 553 (1977). 23. R. Lauwerys. Industrial Chemical Exposure: Guidelines for Biological Monitoring. Biomedical Publications, Davis, CA, 1983, pp 97-98. 24. R Needleman, P. Corr, and E. Johnson, Jr. <strong>Drug</strong>s used for the treatment <strong>of</strong> angina: organic nitrates, calcium channel blockers, and beta-adren- ergic antagonists. In Goodman and Gilman's The Pharmacological Basis <strong>of</strong> Therapeutics, 7th ed. McGraw-Hill, 1985, p813. 25. P. Needleman. Biotransformation <strong>of</strong> organic nitrates. In Organic Nitrates, Handbuch der Experimentellen Pharmakologie, Vol 40. Springer-Verlag, Berlin, 1975, pp 57-96. 26. M. Miller, S. Eloby-Childress, B. Snapp, S. Chotinaruemol, V. Steen, and D. Clark. Urinary nitrite exctretion in premature infants: effects <strong>of</strong> transfusion or indomethacin. Acta Paectiatrica 82:291-295 (1993). 27. J. Hibbs, C. Westenfelder, R. Taintor, Z. Vavrin, R. Baranowski, J. Ward, R. Menlove, M. McMurry, J. Kushner, and W. Samlowski. Evi- dence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89:867-877 (1992). 28. The Merck Index, 12th ed. Merck & Co., Inc., Rahway, NJ, 1996, p 7809. 29. Medical Toxicology. Diagnosis and Treatment <strong>of</strong> Human Poisoning. M. Ellenhom and D. Barceloux, Eds. Elsevier Science Publishing, Inc., New York, NY, 1988, p 844. 30. S. Gautami, R. Rao, T. Rachuram, S. Rajagopalan, and R. Bhat. Acci- dental acute fatal sodium nitrite poisoning. J. ToxicoL-Clin. ToxicoL 33(2): 131-133 (1995). 31. W. Ten Brink, A. Luijpen, A. Van Heijst, S. Pikaar, and R. Seldenrijk. <strong>Nitrite</strong> poisoning caused by food contaminated with cooling fluid. J. ToxicoL-Clin. ToxicoL 19(2):139-147 (1982). Manuscript received August 28, 1997; revision received November 7, 1997. 95